Stock screenerAll disclosures →
EDGAR →
RAPP
Conviction 81HealthcareScan · Thu, Jun 25, 2026RAPP$38.83-2.93%
ResistanceSupportVol 14Insider sell6
6
6
6
5
Vol MA14 342.79K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price38.83
Change-2.93%
Gap+0.80%
Rel volume1.04×
Avg volume315.05K
Avg $ vol11.76M
SMA 2037.49
SMA 5037.05
SMA 20030.30
Price vs 50+4.80%
Price vs 200+28.13%
MA stackbullish
50/200 cross—
Supertrendup · 33.66
RSI (14)55
MACD hist0.20
MACD crossbull · 3d
Stoch %K / %D64 / 75
ADX (14)23
+DI / −DI27 / 14
RSI divergence—
MACD divergence—
ATR %+6.08%
ADR %5.94%
52w high40.00
52w low11.31
From 52w high-2.93%
Above 52w low+243.32%
New 52w highNo
SqueezeOn · 8d
Bollinger width15.86%
%B0.73
Donchian pos63.69%
Donchian high41.86
Donchian low33.51
AVWAP (52w high)29.91
vs AVWAP high+29.83%
AVWAP (52w low)28.60
vs AVWAP low+35.77%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d1.04×
Avg vol (14d)342.79K
Avg vol (20d)315.05K
Avg $ vol (20d)11.76M
Market cap1.86B
RS 3m (vs SPY)+29.34%
RS 6m (vs SPY)+21.92%
RS line new highNo
Trend template8/8
Technical rank76.7
1 week+5.32%
1 month-2.22%
3 months+34.45%
6 months+21.72%
1 year+213.65%
YTD+38.14%
P/E-16.66
P/B3.94
P/S—
P/FCF-21.08
EPS-2.86
Div yield—
ROE-23.64%
ROA-22.40%
Debt/Eq—
Current27.08
EV/EBITDA-14.34
Gross margin—
Net margin—
Rev growth—
EPS growth-42.37%
Price target55.25
Target upside42.29%
Analyst ratingBuy
Institutional113.52%
Ent. value1.78B
Revenue20M
Net income-19.86M
Gross profit—
Free cash flow-88.09M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.83M
Employees84
ListedFri, Jun 7, 2024
Free float29.26M
Float %61.2%
Short interest2.46M
Days to cover8.6d
Short volume37.7%
Squeeze score42 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.88 · 2 est
Last EPS vs est−$0.42 vs −$0.56
Last surprise+25.0% beat
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank76.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance40.76
Support33.66
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RAPP
No recent disclosed trades by Congress in RAPP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RAPP · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
HEALY JAMES Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
PEREZ ROBERT J Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
Young Wendy B. Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
Silva Paul M Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
MARAGANORE JOHN Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
PAUL STEVEN M Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
Sanchez Ramiro Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
Huber Reid M Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 15.2K | $0 | 2026-06-10 | 2026-06-10 |
Third Rock Ventures VI, L.P. 10% owner · Common Stock · 2026-05-26 | Other | — | — | 2026-05-26 | 2026-05-28 |
Third Rock Ventures VI, L.P. 10% owner · Common Stock · 2026-05-26 | Sell | 18.57K | $744K | 2026-05-26 | 2026-05-28 |
SEC filings
EDGAR filings in RAPP · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.